Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

Authors :: Kosmider O
Passet M
Santini V
Platzbecker U
Andrieu V
Zini G
Beyne-Rauzy O
Guerci A
Masala E
Balleari E
Bulycheva E
Dreyfus F
Fenaux P
Fontenay M
Park S
Source :: Haematologica [Haematologica] 2016 Jul; Vol. 101 (7), pp. e280-3. Date of Electronic Publication: 2016 Apr 07.
Publication Year :: 2016

Subjects :: Disease-Free Survival
Female
Humans
Male
Risk Factors
Survival Rate
Hematinics administration & dosage
Mutation
Myelodysplastic Syndromes drug therapy
Myelodysplastic Syndromes genetics
Myelodysplastic Syndromes mortality

Full Text Access

Tools